Financing ·
SciSparc raises $2.55M via convertible notes with up to $10M facility
SPRCSciSparc Ltd.
SciSparc Ltd entered into a Securities Purchase Agreement to issue convertible promissory notes in an aggregate principal amount of up to $10,000,000. At the initial closing on November 3, 2026, the company issued a note with a principal amount of $3,000,000 for a purchase price of $2,550,000. The notes bear interest at 4% annually and are repayable in ten monthly installments beginning eighteen months after issuance. Concurrently, SciSparc issued warrants to purchase up to 11,457,269 ordinary shares at an exercise price of $0.5237, exercisable for three years. Net proceeds will be used for working capital and general corporate purposes. The company operates in the medical technology sector, developing diagnostic imaging solutions.